Is The 4D Medical (ASX: 4DX) Share Price Overhyped?
Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 that a stock I own shares in, Pro Medicus (ASX: PME), had lent 4D Medical $10m.
In part because of the positive attention garnered through this support, the 4D Medical share price has enjoyed an extremely strong run from around 25 cents prior to the announcement to a high of $1.85 on September 8. It has since moderated slightly to $1.63. That equates to a (fully diluted) market capitalisation of around $900m, or approximately 150 times FY 2025 Operating Revenue of $5.9m. In FY 2025 4D Medical made a loss of about $30m…
